Ratio Examination: Novo Nordisk ADR (NVO)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

In the latest session, Novo Nordisk ADR (NYSE: NVO) closed at $83.07 up 0.18% from its previous closing price of $82.92. In other words, the price has increased by $0.18 from its previous closing price. On the day, 6.08 million shares were traded. NVO stock price reached its highest trading level at $83.99 during the session, while it also had its lowest trading level at $82.19.

Ratios:

For a deeper understanding of Novo Nordisk ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.47. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.43.

On May 30, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $156.

On April 12, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $163.BMO Capital Markets initiated its Outperform rating on April 12, 2024, with a $163 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVO now has a Market Capitalization of 361902735360 and an Enterprise Value of 351943557120. As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.94, and their Forward P/E ratio for the next fiscal year is 21.38. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.05 while its Price-to-Book (P/B) ratio in mrq is 15.37. Its current Enterprise Value per Revenue stands at 1.301 whereas that against EBITDA is 2.762.

Stock Price History:

The Beta on a monthly basis for NVO is 0.45, which has changed by -0.22335452 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $80.05. The 50-Day Moving Average of the stock is -16.66%, while the 200-Day Moving Average is calculated to be -32.25%.

Shares Statistics:

For the past three months, NVO has traded an average of 6.91M shares per day and 8102310 over the past ten days. A total of 3.34B shares are outstanding, with a floating share count of 3.34B. Insiders hold about 0.03% of the company’s shares, while institutions hold 9.99% stake in the company. Shares short for NVO as of 1735603200 were 8302268 with a Short Ratio of 1.20, compared to 1732838400 on 5679555. Therefore, it implies a Short% of Shares Outstanding of 8302268 and a Short% of Float of 0.26.

Dividends & Splits

According to the company, the forward annual dividend rate for NVO is 1.45, from 9.9 in the trailing year. Against a Trailing Annual Dividend Yield of 0.11939219The stock’s 5-year Average Dividend Yield is 1.45. The current Payout Ratio is 36.03% for NVO, which recently paid a dividend on 2024-08-16 with an ex-dividend date of 1723766400. Stock splits for the company last occurred on 2023-09-20 when the company split stock in a 2:1 ratio.

Most Popular